Prosecution Insights
Last updated: October 25, 2026

Medwatch Technologies Inc.

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Medwatch Technologies Inc. has 1 pending office action currently in its portfolio. This matter is assigned to 1 distinct examiner. The data shows 0 distinct art units for this pending action, which indicates a specific administrative status for the filing.

JOHNSON, GERALD is the busiest examiner for the company, with a busiest examiner pending count of 1. This examiner is responsible for the single pending office action identified. The company's current prosecution activity is entirely focused on this one examiner's review.

With 1 pending office action and 1 distinct examiner, the company has a very narrow active docket. The 0 distinct art units associated with the case suggest a unique procedural context. Practitioners should focus on the specific requirements of JOHNSON, GERALD to resolve this single pending matter.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
JOHNSON, GERALD 1 78.6% +9.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19292790 BLOOD GLUCOSE ESTIMATION USING NEAR INFRARED LIGHT EMITTING DIODES JOHNSON, GERALD —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19292790 BLOOD GLUCOSE ESTIMATION USING NEAR INFRARED LIGHT EMITTING DIODES JOHNSON, GERALD — §103§112Other Final Rejection — Pending Aug 06, 2025

Managing Medwatch Technologies Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Medwatch Technologies Inc. have?

Medwatch Technologies Inc. has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.

Which USPTO examiner handles the most Medwatch Technologies Inc. applications?

Gerald Johnson has the most, with 1 of Medwatch Technologies Inc.'s pending office actions.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month